| Net income (loss) | 57.6M |
| Depreciation and amortization | 29.4M |
| Changes in cash surrender value of company-owned life insurance | |
| Changes in deferred income taxes | 18.7M |
| Accounts receivable, inventories and accounts payable | |
| Employee compensation liabilities | -70.3M |
| Other assets and liabilities | -14.3M |
| Other | -4.5M |
| Net cash provided by (used in) operating activities | 20.1M |
| Capital expenditures | -26.8M |
| Purchases of short-term investments | -37.2M |
| Liquidations of short-term investments | 74.8M |
| Acquisition, net of divestiture | 0 |
| Other | 400K |
| Net cash provided by (used in) investing activities | 11.6M |
| Repayments of long-term debt | -700K |
| Dividends paid | -29.6M |
| Common stock repurchases | -32.5M |
| Other | |
| Net cash used in financing activities | -63.1M |
| Effect of exchange rate changes on cash and cash equivalents | 1M |
| Net decrease in cash and cash equivalents | -30.4M |
| Cash and cash equivalents, beginning of period | 181.9M |
| Cash and cash equivalents, end of period | 151.5M |